- AZN Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
F-3ASR Filing
AstraZeneca (AZN) F-3ASRAutomatic shelf registration (foreign)
Filed: 21 Dec 10, 12:00am
New York (State of incorporation if not a U.S. national bank) | 13-5160382 (I.R.S. employer identification no.) |
One Wall Street, New York, N.Y. (Address of principal executive offices) | 10286 (Zip code) |
England and Wales (State or other jurisdiction of incorporation or organization) | Not Applicable (I.R.S. employer identification no.) |
15 Stanhope Gate London W1K 1LN England (Address of principal executive offices) | Not Applicable (zip code) |
(a) | Name and address of each examining or supervising authority to which it is subject. |
Name | Address |
Superintendent of Banks of the State of New York | 2 Rector Street, New York, N.Y. 10006, and Albany, N.Y. 12203 |
Federal Reserve Bank of New York | 33 Liberty Street, New York, N.Y. 10045 |
Federal Deposit Insurance Corporation | 550 17th Street, N.W. Washington, D.C. 20429 |
New York Clearing House Association | New York, New York 10005 |
(b) | Whether it is authorized to exercise corporate trust powers. |
2. | Affiliations with Obligor. |
3-15. | Pursuant to General Instruction B of the Form T-1, no responses are included or Items 3-15 of this Form T-1 because, to the best of the Trustee’s knowledge, the obligor is not in default under any Indenture for which the Trustee acts as Trustee and the Trustee is not a foreign trustee as provided under Item 15 . |
16. | List of Exhibits. |
THE BANK OF NEW YORK MELLON | |||
By: | /s/ | Timothy E. Burke | |
Name: | Timothy E. Burke | ||
Title: | Vice President |
ASSETS | Dollar Amounts In Thousands | |||
Cash and balances due from depository institutions: | ||||
Noninterest-bearing balances and currency and coin | 2,892,000 | |||
Interest-bearing balances | 71,640,000 | |||
Securities: | ||||
Held-to-maturity securities | 3,857,000 | |||
Available-for-sale securities | 55,342,000 | |||
Federal funds sold and securities purchased under agreements to resell: | ||||
Federal funds sold in domestic offices | 18,000 | |||
Securities purchased under agreements to resell | 778,000 | |||
Loans and lease financing receivables: | ||||
Loans and leases held for sale | 16,000 | |||
Loans and leases, net of unearned income | 24,990,000 | |||
LESS: Allowance for loan and lease losses | 517,000 | |||
Loans and leases, net of unearned income and allowance | 24,473,000 | |||
Trading assets | 8,311,000 | |||
Premises and fixed assets (including capitalized leases) | 1,140,000 | |||
Other real estate owned | 7,000 | |||
Investments in unconsolidated subsidiaries and associated companies | 916,000 | |||
Direct and indirect investments in real estate ventures | 0 | |||
Intangible assets: | ||||
Goodwill | 6,371,000 | |||
Other intangible assets | 1,852,000 | |||
Other assets | 13,262,000 | |||
Total assets | 190,875,000 |
LIABILITIES | ||||
Deposits: | ||||
In domestic offices | 64,871,000 | |||
Noninterest-bearing | 34,508,000 | |||
Interest-bearing | 30,363,000 | |||
In foreign offices, Edge and Agreement subsidiaries, and IBFs | 80,811,000 | |||
Noninterest-bearing | 2,198,000 | |||
Interest-bearing | 78,613,000 | |||
Federal funds purchased and securities sold under agreements to repurchase: | ||||
Federal funds purchased in domestic offices | 3,192,000 | |||
Securities sold under agreements to repurchase | 27,000 | |||
Trading liabilities | 9,222,000 | |||
Other borrowed money: (includes mortgage indebtedness and obligations under capitalized leases) | 2,228,000 | |||
Not applicable | ||||
Not applicable | ||||
Subordinated notes and debentures | 3,490,000 | |||
Other liabilities | 11,236,000 | |||
Total liabilities | 175,077,000 | |||
EQUITY CAPITAL | ||||
Perpetual preferred stock and related surplus | 0 | |||
Common stock | 1,135,000 | |||
Surplus (exclude all surplus related to preferred stock) | 8,565,000 | |||
Retained earnings | 6,545,000 | |||
Accumulated other comprehensive income | -809,000 | |||
Other equity capital components | 0 | |||
Total bank equity capital | 15,436,000 | |||
Noncontrolling (minority) interests in consolidated subsidiaries | 362,000 | |||
Total equity capital | 15,798,000 | |||
Total liabilities and equity capital | 190,875,000 |
Robert P. Kelly Gerald L. Hassell Catherine A. Rein | ![]() | Directors |